INTRODUCTION
The inwardly rectifying potassium channel Kir4.1 is a tetrameric transmembrane protein expressed in multiple organ systems. Within the central nervous system (CNS) Kir4.1 is expressed in glia, including the principal glial cell type in the retina, the M€ uller cell (Kofuji et al., 2000) . Kir4.1 is implicated in the process of ''potassium siphoning'' (Newman and Odette, 1984) , a mechanism of potassium buffering that helps stabilize the extracellular potassium concentration ([K 1 ] o ) in the face of neuronallyderived ion fluxes (Amedee et al., 1997; Kofuji et al., 2000; Kofuji and Connors, 2003) .
M€ uller cells have a bipolar morphology and are arranged in a radial fashion, spanning almost the entire width of the neural retina. A unique property of Kir4.1 within these cells is its subcellular localization, being highly concentrated in M€ uller cell endfeet and in perivascular processes (Nagelhus et al., 1999; Kofuji et al., 2000) . This localization pattern is thought to facilitate the potassium siphoning mechanism by enrichment of Kir4.1 in cellular regions where K 1 can be released from M€ uller cells without altering the stability of neuronal physiology (Odette and Newman, 1988; Newman and Reichenbach, 1996) .
Interestingly, the water channel aquaporin-4 (AQP4) maintains a very similar distribution pattern to that of Kir4.1 in M€ uller cells (Nagelhus et al., 1999) . Recent findings suggest that AQP4 may also be necessary for effective [K 1 ] o buffering in brain (Amiry-Moghaddam et al., 2003a; Nagelhus et al., 2004) . The co-localization of this channel with Kir4.1 in M€ uller cells suggests a common molecular mechanism for their consolidation in these subcellular regions (Nagelhus et al., 2004) .
Studies by our group and others have revealed that both Kir4.1 (Connors and Kofuji, 2002; Connors et al., 2004) and AQP4 (Neely et al., 2001; Amiry-Moghaddam et al., 2003a) can interact with the multi-protein dystrophin-glycoprotein complex (DGC) in brain and astrocytes. This group of proteins has been best described in muscle, where it may be involved in calcium homeostasis or the maintenance of structural integrity required for myocytes to withstand muscular contractile forces (Mehler, 2000) . A specific arrangement of the DGC in M€ uller cells was recently described (Claudepierre et al., 2000) . At its core, this complex includes the PDZ domain protein a-syntrophin, the short dystrophin isoform Dp71, the transmembrane protein b-dystroglycan, and the extracellular matrix receptor a-dystroglycan (Claudepierre et al., 2000) .
Recent studies have shown that mutations in DGC proteins underlie a variety of muscular dystrophies (Michele and Campbell, 2003) . Such mutations also result in structural and physiological changes within the CNS, revealing an important role for the DGC in brain function. For example, a mutant form of a-dystroglycan results in structural anomalies within the brain and prevents the onset of hippocampal LTP (Moore et al., 2002) . Dystro-phin mutants also show abnormal electroretinogram (ERG) profiles (Pillers et al., 1999a,b; Dalloz et al., 2003) , and the elimination of Dp71 results in the mislocalization of both Kir4.1 and AQP4 in mouse retina (Connors and Kofuji, 2002; Dalloz et al., 2003) .
Although we previously showed that Kir4.1 can be localized in M€ uller cells by Dp71 (Connors and Kofuji, 2002) and that Kir4.1 interacts directly with the DGC via a-syntrophin in brain and astrocytes (Connors et al., 2004) , we have yet to describe in detail the molecular interactions between the DGC and Kir4.1 in M€ uller cells. In this study we show that in the retina Kir4.1 can form a stable complex with members of the DGC including dystrophin, syntrophin, and dystrobrevin, and moreover can interact with AQP4 possibly by co-associations with DGC proteins.
MATERIAL AND METHODS Antibodies
Rabbit anti-Kir4.1 generated against the peptide CEKEGSALSVRISNV and characterized previously (Kofuji et al., 2000) was used as a pulldown antibody in immunoprecipitation (IP) assays (5 lg/reaction) and as a probe for Western blots (1-2.5 lg/ml). Anti-aquaporin-4 was obtained from either Chemicon (Temecula, CA) or Alamone Laboratories (Jerusalem, Israel) and used at 0.1-0.2 lg/ml for Western blotting, and 3 lg for each IP pulldown. Mouse monoclonal anti-glutamine synthetase clone GS-6 (Chemicon) was used at 5 lg/ml for retinal slice immunocytochemistry. Guinea pig anti-GLAST (Chemicon) used for ICC at 1:4,000 of the manufacturer's stock as a M€ uller cell marker and as a probe for Western blots at 1:5,000. Rabbit polyclonal anti-a-syntrophin antibody was obtained from Sigma (St. Louis, MO) and used as a pulldown antibody for IPs at 3-5 lg per pulldown or at 7.7 lg/ml as a probe for Western blots. Monoclonal pansyntrophin antibodies from Affinity Bioreagents (ABR, Golden, CO) were used for Western blotting at 0.2 lg/ml. Monoclonal anti-dystrophin (clone 6C5) from Chemicon was used at 1:20 of manufacturer stock for probing Western blots. Mouse anti-b-dystroglycan monoclonal antibody (clone 43DAG1/8D5) from Novacastra (Newcastle upon Tyne, UK) was used for immunoprecipitation assays (100 ll/reaction) and at 1:50 for probing Western blots. AlexaFluor secondary antibodies (Molecular Probes, Eugene, OR) produced in goat were used, including antirabbit 488 and 594, anti-mouse 488 and 594, and anti-guinea pig 488 and 594. For detection on Western blotting, peroxidase-conjugated anti-mouse (working concentration 1:30,000) or anti-rabbit (1:20,000) were used (Jackson ImmunoResearch, West Grove, PA).
Immunocytochemistry
Immunocytochemistry was performed with adult postnatal day 21 (P21) to P26 wild-type (C57BL/6J) mice (Jackson Laboratory, Bar Harbor, ME) using previously described procedures (Connors and Kofuji, 2002) .
Chemical Crosslinking, Immunoprecipitation, and Western Blotting
Frozen rat retinas (Pel Freez, Rogers, AK) were dissected in room temperature phosphate-buffered saline (PBS) and then dropped into pre-DSP crosslink buffer (250 lM sucrose, 7.5 mM Na 2 HPO 4 , 5 mM EGTA, 5 mM EDTA (pH 7.4), and Complete protease inhibitor mixture (Roche Diagnostics, Indianapolis, IN)) on ice at a ratio of 1.8 ml buffer per 30 retinas. Retinas were then homogenized on ice by repeated aspiration through a syringe and 18 gauge needle, then 2 mM dithiobis(succinimidyl propionate) (DSP; Pierce, Rockford, IL) was dissolved in DMSO and added to the homogenate for a final concentration of 200 lM. Retinas were crosslinked at room temperature for 30 min until the reaction was stopped by the addition of Tris (pH 7.4) to a final concentration of 50 mM. The tube was then put back on ice and retinal tissue was lysed by the addition of 150 mM NaCl and 1% Triton X-100 at 4°C for 1 h, then spun down in a microcentrifuge at 4°C at 14,000 rpm for 10 min. The supernatant was collected and spun again, then used immediately thereafter. All the following steps were performed on ice or at 4°C, except for centrifugations of the Sepharose beads. After retinal lysates were prepared, they were precleared by incubation for 1-3 h with 50 ll protein A-or G-Sepharose beads, which were then removed by centrifugation and recovery of the supernatant. Lysates from 30 rat retinas were divided equally into two parts; one was spiked with the pulldown antibody, while the other was not, and both were incubated overnight on a mechanical rotator. The next day, 20-30 ll Sepharose beads previously blocked in 2% bovine serum albumin (BSA) were added to each of the IP and the non-IP reactions and incubated on the rotator for 1 h. Following incubation, a small amount of the non-IP (beads-only) sample was recovered for the input lane. Samples were washed in lysis buffer consisting of 50 mM Tris (pH 7.4), 150 mM NaCl, 50 mM EGTA, and 0.1% Triton X-100 fortified with Complete protease inhibitor a total of 5 times. After the final wash, the Sepharose beads as well as the input sample were resuspended in NuPage loading buffer (Invitrogen) prepared according to the manufacturer's instructions, and heated at 70°C for 10 min. Western blots were performed using NuPAGE BisTris 4-12% gradient gels (Invitrogen, San Diego, CA) as described previously (Connors et al., 2004) .
RESULTS

Kir4.1 Interacts With DGC in Retina
Our prior research (Connors and Kofuji, 2002) demonstrated that Dp71 is critical for the subcellular localization of Kir4.1 in M€ uller cells within the retina. Our goal in the present study is to describe the molecular interactions involved in this localization of Kir4.1 as well as AQP4. We first performed immunostaining experiments on mouse retina to reveal the distribution of both channels. Figure 1 shows that the localization pattern of both Kir4.1 and AQP4 are very similar within the retina. Specifically, both channels are localized to the vitreal border, corresponding to staining within M€ uller cell endfeet (Fig. 1A ,D, arrows) as well as in perivascular processes in outer retinal layers (Fig. 1A ,D, arrowheads). Kir4.1 appears to be highly enriched in these areas as very little staining for the channel is seen elsewhere throughout the retina. The staining for AQP4 also shows this highly polarized distribution; however, notable staining can also be seen in the outer plexiform layer (OPL) and throughout the inner plexiform layer (IPL). These results are in agreement with previous findings (Dalloz et al., 2003; Nagelhus et al., 1999) , confirming that Kir4.1 and AQP4 are specifically localized to particular subcellular regions within M€ uller cells. Similar results were also observed in rat retinas (results not shown).
Our prior data revealed that when dystrophins are absent from the retina, Kir4.1 no longer maintains such a polarized localization pattern within M€ uller cells, and a more homogeneous distribution is observed (Connors and Kofuji, 2002) . Based on this information, we sought to determine whether the channel can directly interact with members of the DGC in the retina. We first asked whether the IP of Kir4.1 can result in the recovery of the short dystrophin isoform Dp71, implicated as the primary subtype of dystrophin in M€ uller cells (Claudepierre et al., 1999) . We employed the crosslinking reagent DSP for the current studies to minimize instability of interactions between channel and the DGC. This reagent has previously been used by other groups to stabilize interactions between the transmembrane channels and their interaction partners (Zhu et al., 1999; Neely et al., 2001) . Whole retinas from rats were isolated, chemically crosslinked, then incubated with antibodies against Kir4.1. The protein complexes recovered with protein A-Sepharose beads were eluted, processed through sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) Western blotting, and then probed with antibodies against dystrophin.
The results of the above experiment showed a prominent band slightly lower than 75 kDa when lysates were precipitated with anti-Kir4.1 ( Fig. 2A , IP:Kir4.1) and probed with anti-dystrophin antibodies, indicating the recovery of Dp71. Two higher-molecular-weight bands were also seen: one slightly larger than 100 kDa and one at 150 kDa. While Dp71 is purportedly the only dystrophin expressed in M€ uller cells, the larger isoforms Dp140 and Dp260 are also likely expressed in other areas of the retina (Howard et al., 1998; Claudepierre et al., 1999) . The larger dystrophin-positive bands seen in Figure 2A resemble the two distinct isoforms of Dp140 (Austin et al., 1995) , suggesting that Dp140 may also interact with Kir4.1 in the retina. All bands recovered in the IP lane resemble those seen in nonprecipitated lysates ( Fig. 2A , input lane). Nonspecific bands were detected when pulldown antibody was omitted ( Fig. 2A , pA lane), possibly arising from retinal immunoglobulins, yet the mobilities of these bands did not interfere with the detection of dystrophin-positive bands ( Fig. 2A , IP:Kir4.1 lane). Together this evidence strongly suggests that dystrophins and Kir4.1 form a macromolecular complex in retina.
To help further verify whether the bands seen following the IP of Kir4.1 correspond to dystrophins, retinal lysate was also immunoprecipitated with antibodies against the known dystrophin binding partner, a-syntrophin. Upon probing these blots with antibodies against dystrophin, bands that appeared to correspond to Dp71 and Dp140 were revealed ( Fig. 2A , IP:a-syn lane), and matched closely the bands observed in the IP of Kir4.1. This provides further evidence that the bands recovered by the IP of Kir4.1 correspond to isoforms of dystrophin.
Other IP experiments were performed to further characterize the interaction between Kir4.1 and the DGC in the retina. During one such experiment, the IP of Kir4.1 resulted in the recovery of a band with a molecular weight slightly less than 75 kDa when probed with a pan-syntrophin antibody (Fig. 2B, top) . Syntrophins have been shown to migrate at 58 kDa on SDS-PAGE (Froehner et al., 1987; Adams et al., 1995; Suzuki et al., 1995) , which is consistent with the band seen on our blot.
Another DGC component, dystrobrevin, is an intracellular protein of 87 kDa that associates with both dystrophin and syntrophin (Peters et al., 1997; Sadoulet-Puccio et al., 1997) . When samples precipitated with anti-Kir4.1 were probed with antibodies against dystrobrevin, a band slightly greater than 75 kDa was detected (Fig. 2B , bottom), suggesting that this protein also interacts with Kir4.1. In both experiments, omission of the pulldown antibody resulted in the failure to recover the DGC protein (Fig. 2B, pA lanes) .
To help reinforce some of the findings outlined thus far, some reverse experiments were performed by immunoprecipitating selected DGC components, then probing for Kir4.1. We first used antibodies against Kir4.1 to pulldown the channel protein, then probed the membrane for Kir4.1 to verify the migration rate of Kir4.1 on SDS-PAGE in these experiments. It has been shown consistently on Western blots that it is difficult to completely dissociate Kir4.1 from a tetrameric state (Li et al., 2001; Connors and Kofuji, 2002) , although incomplete denaturation usually occurs. As a result, we frequently see multiple bands corresponding to the four possible quarternary arrangements of channel subunits. The monomers tend to migrate around 43 kDa, which is close to the molecular weight of heavy-chain immunoglobulins as well as other nonspecific bands, so for clarity we show the tetrameric band, which runs at 180 kDa. When we performed immunoprecipitation for Kir4.1 then probed the blot for the channel, a band slightly under 200 kDa was seen (Fig. 3 , first panel) which is close to the calculated molecular weight for tetrameric Kir4.1 and is in agreement with prior studies (Li et al., 2001; Connors and Kofuji, 2002) .
To verify whether we could recover Kir4.1 by pulling down DGC proteins, retinal lysates were first precipitated with anti-b-dystroglycan antibodies. When lysates from this experiment were probed with anti-Kir4.1, a band slightly under 200 kDa (Fig. 3, second panel) was observed, indicating the recovery of the tetrameric form of the channel. We then used anti-a-syntrophin antibodies for IP, which also resulted in the recovery of tetrameric Kir4.1 (Fig. 3, third panel) . In both IPs, the omission of the pulldown antibody did not result in the recovery of Kir4.1.
The results outlined thus far suggest that Kir4.1 can co-precipitate with a number of DGC proteins in the retina. These proteins include Dp71 (and possibly Dp140), a-syntrophin and perhaps other syntrophin isoforms, bdystroglycan, and dystrobrevin. These results provide strong evidence that Kir4.1 forms a complex with DGC components in M€ uller cells.
AQP4 Interacts With Kir4.1 and DGC in Retina
A shared localization mechanism for Kir4.1 and AQP4 in retina is suggested by the tight co-localization of these Fig. 2 . Kir4.1 associates with dystrophin isoforms in rat retinas. A, When retinal tissue was immunoprecipitated with antibodies against Kir4.1 and probed with anti-dystrophin antibodies (IP:Kir4.1 lane), a number of immunopositive bands were detected. The most intense band was seen at just under 75 kDa, indicating that this protein was Dp71. Two larger bands were also seen at 100-150 kDa, likely corresponding to isoforms of Dp140. IP with antibodies against a-syntrophin (IP:a-syn) resulted in recovery of the same isoforms of dystrophin as did Kir4.1. B, Retinal lysates were chemically crosslinked, incubated with antibodies against Kir4.1, and then processed via SDS-PAGE and Western blotting using anti-pan-syntrophin antibodies (top) and anti-pan-dystrobrevin (bottom) antibodies. Since syntrophins have a molecular weight of 59 kDa and dystrobrevin at 87 kDa, the bands detected in the IP lane in each blot (IP:Kir4.1) indicate the presence of these two proteins. In neither case did the protein A-Sepharose matrix nonspecifically pull down the proteins of interest. Numbers on the right refer to the relative electrophoretic mobility of pre-stained molecular mass standards. Fig. 3 . Kir4.1 co-precipitates with DGC proteins and AQP4 in retina. First panel, retinal tissue was homogenized chemically crosslinked and immunoprecipitated with antibodies against Kir4.1. The sample was processed through SDS-PAGE and Western blotting and probed with antibodies against Kir4.1, showing a band at 180 kDa corresponding to the tetrameric form of the channel. Precipitation with protein A-Sepharose only (pA, left lane) did not pull down Kir4.1. Second and third panels, when lysates were immunoprecipitated with antibodies against b-dystroglycan and a-syntrophin, respectively, a 180-kDa band was seen after probing with anti-Kir4.1 antibodies. When anti-AQP4 were used as pulldown antibodies, Kir4.1 was recovered (last panel). In all experiments when the pulldown antibody was omitted and lysates were incubated with protein A-Sepharose only (pA lanes) Kir4.1 was not recovered. Numbers on the right refer to the relative electrophoretic mobility of pre-stained molecular mass standards.
proteins in the endfeet and perivascular processes of M€ uller cells shown in Figure 1 and in prior studies (Nagelhus et al., 1999) . Furthermore, AQP4 was shown to interact with the DGC in M€ uller cells (Dalloz et al., 2003 ) and brain astrocytes (Amiry-Moghaddam et al., 2003a Neely et al., 2001) . Based on this evidence, experiments were conducted to examine whether AQP4 can interact with DGC proteins and also with Kir4.1 in retina.
Based on the previously shown interactions between AQP4 and a-syntrophin in brain (Amiry-Moghaddam et al., 2003a; Neely et al., 2001) , AQP4 was first immunoprecipitated from rat retinal lysate, then probed with pan-syntrophin antibodies. The results of this experiment show that a protein slightly less than 75 kDa was recovered (Fig. 4 , top, IP:AQP4 lane). This finding suggests that AQP4 forms a complex with syntrophin in the retina. Anti-AQP4 immunoprecipitates were also probed for the presence of the 43 kDa transmembrane DGC component, b-dystroglycan. When antibodies against b-dystroglycan were used to probe the blot, a band slightly larger than 37 kDa was seen in the IP lane (Fig. 4, middle) , suggesting that AQP4 also interacts with b-dystroglycan in the retina.
To determine whether the interaction between AQP4 and syntrophin is mediated specifically by the a isoform of syntrophin in retina, anti-a-syntrophin antibodies were used for IP of rat retina lysate. When the blots were probed with anti-AQP4, a band of 100-150 kDa was revealed (Fig. 5,  right) . Prior studies showed that under certain conditions, including with the use of the crosslinker DSP, AQP4 migrates as a tetramer (Neely et al., 1999). Figure 5 (left) shows that when AQP4 is immunoprecipitated and then probed with anti-AQP4 antibodies, a band is seen at 100-150 kDa, which is consistent with the expected molecular weight of the tetrameric form of this channel.
One concern about the use of chemical crosslinkers is the possible introduction of artifactual interactions. To address this issue, antibodies were chemically stripped from the blot shown in Figure 4 (top); the membrane was then reprobed with antibodies against GLAST. A GLAST immunopositive band can be seen at 50-75 kDa in the lysate, however, is undetectable in the lane corresponding to the IP of AQP4 (Fig. 4, bottom, last lane) . This demonstrates that these two membrane proteins were not induced to interact nonspecifically and suggests that DSP does not promiscuously introduce protein-protein interactions at the cell membrane.
Since the above data suggest that Kir4.1 and AQP4 can each interact with members of the DGC in retina, the next goal was to address whether Kir4.1 and AQP4 might interact through a common linkage with the DGC. To address this hypothesis, AQP4 was first immunoprecipitated from retinal lysate, which was then probed with Fig. 4 . AQP4 co-precipitates with DGC components in retina. Top: Anti-AQP4 antibodies were used to immunoprecipitate retinal lysates and the Western blot was probed with pan-syntrophin antibodies, revealing a band at 58 kDa (last lane). This band was not when precipitated with protein A-Sepharose alone (middle lane). Middle: Same experiment was performed, but the blot was probed with anti b-dystroglycan antibodies, revealing a band in the IP lane (IP:AQP4) that is not seen in the protein A-Sepharose (pA), suggesting that AQP4 and b-dystroglycan form a complex in retina. Bottom: Antibodies on the blot shown in A were stripped and the blot was reprobed with anti-GLAST antibodies to determine whether the use of the crosslinking reagent, DSP, may introduce artifactual interactions. GLAST is seen in the input lane migrating at 63 kDa, but was not recovered by the IP reaction (IP:AQP4), suggesting that the interactions between AQP4 and the DGC are specific. Numbers on the right refer to the relative electrophoretic mobility of pre-stained molecular mass standards. Fig. 5 . AQP4 co-precipitates with a-syntrophin and Kir4.1 in retina. Left: retinal tissue was immunoprecipitated with antibodies against Kir4.1 (IP:Kir4.1) and AQP4 (IP:AQP4) then probed with anti AQP4 antibodies. The first lane (pA) shows that the protein A-Sepharose matrix did not recover AQP4 alone. The second lane shows a band at 120 kDa which corresponds to the tetrameric form of AQP4. The electrophoretic migration of AQP4 was verified to result in a band at~120 kDa when AQP4 was immunoprecipitated and the blot was probed with anti-AQP4 antibodies. When anti-a-syntrophin (right) were used as pulldown antibodies, a band at 120 kDa was revealed after probing with antibodies against AQP4, suggesting that the water channel also associates with this protein in retina. Numbers on the right refer to the relative electrophoretic mobility of pre-stained molecular mass standards.
anti-Kir4.1 antibodies. As shown in Figure 3 (last panel), the tetrameric band of Kir4.1 slightly less than 200 kDa was revealed from the precipitated lysate, suggesting that these two channels can form a complex. The reverse experiment was also performed: the IP of Kir4.1 and probe for AQP4 resulted in the detection of a band of 100-150 kDa, indicative of the tetrameric band of AQP4 (Fig. 5, left) . Collectively, the evidence from the above experiments suggests that Kir4.1, AQP4, and the DGC can form a multi-protein complex in the retina.
DISCUSSION
Prior studies used cultured M€ uller cells to characterize the DGC in vitro (Claudepierre et al., 2000) . Our data extends that knowledge by using tissue from intact retina to further characterize DGC interactions in vivo, and by examining the ability for the this complex to play a role in transmembrane channel localization. Using IP assays, we found compelling evidence for associations in the retina between Kir4.1 and a number of dystrophin-glycoprotein complex components, including dystrophin, a-syntrophin, b-dystroglycan and dystrobrevin. We also provided evidence that the water channel AQP4 can co-precipitate with DGC proteins and Kir4.1. Together, these findings suggest a model whereby both channels are linked through the DGC, and further describe one of the few known mechanisms of subcellular localization of ion channels in glial cells.
The study of dystrophins is complicated by the large number of dystrophin isoforms expressed in vivo and their variable tissue distributions. In total, there are 18 different dystrophins, which include splice variants of the major isoforms: Dp427, Dp260, Dp140, Dp116, and Dp71. All dystrophin isoforms have been identified within the CNS, and most can be found within the eye (Mehler, 2000) . In the retina, Dp427 and Dp260 are localized to photoreceptor terminals in the OPL Howard et al., 1998) , while Dp140 and a particular isoform of Dp71 are likely expressed in retinal astrocytes (Claudepierre et al., 1999) . It was reported that M€ uller cells also express a specific Dp71 isoform lacking exon 78, known as Dp71f (Claudepierre et al., 1999) . However, one study showed that antibodies produced against a purported astrocyte-specific isoform can actually react with the Dp71 in M€ uller cells (Howard et al., 1998) , suggesting that there may still be some ambiguity with regard to the distribution of specific Dp71 isoforms throughout the retina. Our findings that Kir4.1 can co-precipitate with Dp71 as well as Dp140 suggests that either Dp140 is expressed in M€ uller cells or that Kir4.1 is expressed elsewhere in the retina, such as in astrocytes of the nerve fiber layer, where Dp140 may be expressed (Claudepierre et al., 1999) . Unfortunately due to the intensity of Kir4.1 immunostaining in M€ uller cell endfeet, it is impossible at the light microscopic level to discern astrocytic Kir4.1 staining from that found in M€ uller cell endfeet.
Along with the expression of multiple dystrophins, further DGC complexity arises from the number of syntrophin isoforms that have been identified. Aside from a-syntrophin, the ubiquitously expressed b 1 and b 2 (Ahn et al., 1996) and the brain-specific g 1 and g 2 isoforms (Piluso et al., 2000) have all been characterized. Furthermore, recent studies showed that there can be up to four distinct syntrophin binding sites within a single DGC, which can theoretically bind any combination of syntrophin (Peters et al., 1997; Newey et al., 2000) . The differential expression patterns of these syntrophins within the CNS are still under investigation. It is tempting to speculate that the recruitment of particular molecules to the DGC could be regulated by the arrangement of syntrophin isoforms present. The number of dystrophins and syntrophins that are expressed make for the possibility of an elaborate matrix of interactions between the DGC, Kir4.1, and AQP4 within the CNS.
Over the last couple of years, research in this area has revealed an apparent interdependence between syntrophins, Kir4.1 and AQP4. For example, all three proteins tend to be upregulated in a parallel fashion in human astrocytes after a number of pathological brain states (Saadoun et al., 2003) . These two channels plus a-syntrophin and other DGC members also aggregate in glia when presented with laminin in cell culture (Guadagno and Moukhles, 2004 ). In addition, immunolocalization studies have shown that Kir4.1 and AQP4 are tightly co-localized in rat retina (Nagelhus et al., 1999) , and AQP4 localization in astrocytes appears to be highly dependent on a-syntroin (Inoue et al., 2002) . Direct interactions between AQP4, a-syntrophin, Dp71 and b-dystroglycan have been shown by IP assays (Neely et al., 2001; Amiry-Moghaddam et al., 2003a,b) . Finally, the specific loss of Dp71 eliminates the polarized distribution of both Kir4.1 and AQP4 in retina (Dalloz et al., 2003) . Overall, these reports describe a convincing body of evidence that Kir4.1, AQP4 and DGC proteins are closely interrelated in some way.
Despite the apparent relationship between these proteins, there may be differences in the way Kir4.1 and AQP4 interact with the DGC. For example, immunoelectron microscopy showed that the absence of a-syntrophin dramatically altered the localization pattern of AQP4 but not Kir4.1 in hippocampal astrocytes (Amiry-Moghaddam et al., 2003a) . Similar evidence has been proposed in retinas from a-syntrophin null mice where the localization of AQP4 was marginally decreased in M€ uller cell endfeet and perivascular processes, whereas Kir4.1 localization was unaffected (Frydenlund et al., 2004) .
Biochemical studies have demonstrated that there may be specificity of interactions between particular syntrophins and their binding partners. This idea is lent credence by the findings that PDZ domains can discriminate interaction partners based on single amino acid substitutions (Songyang et al., 1997; Gee et al., 2000; Vaccaro et al., 2001) . Therefore, the differences in the PDZ domain-binding C-termini of Kir4.1 (-R-I-S-N-V) and AQP4 (-V-L-S-S-V) may facilitate the preferential binding of AQP4 to a particular syntrophin isoform and Kir4.1 to another. Moreover, slight sequence differences within the PDZ domains of syntrophins may also purvey selectivity for particular binding partners.
The interactions between the DGC, Kir4.1, and AQP4 may influence the efficiency of the glial [K 1 ] o buffering function. Modeling studies (Odette and Newman, 1988) suggest that the enrichment of K 1 channels at the endfeet of M€ uller cells enhance K 1 buffering. Our studies show a redistribution of K 1 conductances in the mdx 3Cv mouse which could potentially alter K 1 fluxes in retina. There is also evidence that AQP4 is involved in [K 1 ] o buffering. First, the volume of the extracellular space in brain appears to be negatively correlated with [K 1 ] o , suggesting the involvement of a water transport mechanism (Dietzel et al., 1980; Holthoff and Witte, 2000) . Second, a-syntrophin null mice show an impairment of both water transport and K 1 buffering in brain resulting from a redistribution of AQP4 away from astrocytic endfeet (AmiryMoghaddam et al., 2003b (AmiryMoghaddam et al., , 2004 . Finally, following an experimentally induced loss of Kir4.1 in retina, ischemic conditions resulted in increased cell swelling under hypoosmotic conditions (Pannicke et al., 2004) . As a group, these data suggest that water and K 1 transport are tightly coupled, which could stem from the co-associations of Kir4.1 and AQP4 with the DGC.
